The combined treatment induced the enrichment of the sub-G1 cell population and enhanced the pro-apoptotic effect along with an increase in the expression of cleaved caspase-3 and cleaved PARP in HCC cells. The gene discussed is CASP3; the disease is hepatocellular carcinoma.